The proposed move assumes significance in the wake of several auditors in the recent past decided to exit from their audit mandate.
SAT partly allowed disgorgement of the Rs 13 crore fee from the auditor.
Sun Pharma, however, did not provide any specific details on the reasons for the SEBI to order the forensic audit.
The limit for FPI investment in debt was revised from Rs 6.49 lakh cr to over Rs 6.98 lakh cr for the April 2019-Sept 2019.
The shares of Mid-Cap and Small-Cap companies have seen huge price erosion in recent times.
The Nifty has fallen 316.15 points, or 2.86 per cent in three consecutive trading sessions.
Officials said there have been occasions when some entities have sought to take the benefit of certain regulatory gaps.
Offshore funds of Indian MFs can now invest as FPIs.
Currently, listed companies should have at least 25 per cent public shareholding.
Securities and Exchange Board of India had asked HPCL to re-file shareholding pattern to stock exchanges by August 13, 2019.